Based on the above experiments, we believe that glioblastoma cells were reprogrammed to a neural differentiation phase in a dynamic balance of UNC5B receptor-induced cell death via DAPK1-P53 pathway and promotion of axonal growth via RGMA-RhoA pathway 45, 46 (Figure 8H). Here, RGMA is linked to glioblastoma.